Today's Lists on Stockpickr
After the market close, Stockpickr updates a series of portfolios called Today's Lists with information from that trading day. It's a useful tool for getting a quick picture of how the market moved that day.
If you are a Stockpickr member and have a Today's List stock in one of your portfolios, you'll receive an email alert after that list is updated. You can become a Stockpickr member here.
Here's a sampling of what made Today's Lists today, July 14:
52-Week Highs: Noven Pharmaceuticals (NOVN) swung to a 52-week high of $16.49 today on news that it will be bought by Hisamitsu Pharma for $16.50 a share. The stock closed up $3, or 22.3%, for the day at $16.48. Cypress Semiconductor (CY) also hit a year high, of $9.45, before closing up 1.5% for the day at $9.32.
52-Week Lows: Stocks hitting 52-week lows today included CardioNet (BEAT), Hansen Medical (HNSN) and Raser Tech (RZ). Biggest % Gainers: Hi-Tech Pharmacal (HITK) gained 28.9% to close at $12.75 on a surge in fourth-quarter profit. American Apparel (APP) was also up big, gaining 18% for the day to close at $3.60. Biggest % Losers: Humana (HUM) and HealthNet (HNT) lost 7.6% and 14.7%, respectively, after the Pentagon announced on Monday that it would not be renewing military health insurance contracts with the companies. Rising on Unusual Volume: Noven's rise today was on a 4,113% increase in volume. Analyst Upgrades: Upgrades today included JPMorgan's upgrade of Prudential (PRU) to overweight from neutral and Jefferies' upgraded of VMware (VMW) to hold from underperform. See all of Today's Lists here, including TheStreet.com TV Videos, TheStreet.com TV Videos and Analyst Downgrades.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV